Altasciences acquires California-based CRO WCCT Global

Altasciences has acquired WCCT Global, an early stage clinical research organization (CRO) based in Southern California, for an undisclosed price.

The Canada-based mid-size CRO/CDMO said that the acquisition will complement its existing clinical operations in Montreal and Kansas City, while being in close proximity to its preclinical facility in Washington State.

Steve Mason – Co-Chief Operating Officer at Altasciences said: “This acquisition expands Altasciences’ footprint by providing Phase I and II clinical pharmacology services on the West Coast, and adds 180 beds to our current 400-bed offering. Furthermore, it allows us to enhance our capabilities with expertise in ethnobridging and other specialty areas for hard-to-recruit study populations.”

Altasciences acquires California-based CRO WCCT Global. Photo courtesy of Adam Radosavljevic from Pixabay.

Established in 1998, WCCT Global is said to have carried out more than 600 Phase I studies.

Gregory Hanson – Executive Chairman of WCCT Global said: “Joining the Altasciences team will enhance our offering while allowing us to continue the responsive delivery of quality research data to our global biopharmaceutical clients.”